NDC 61434-038 – Durvalumab
Durvalumab 120 mg/2.4mL · Injection, Solution
Product NDC61434-038
Product details
- Brand name
- Durvalumab
- Generic name
- Durvalumab
- Labeler
- Catalent Indiana, LLC
- Dosage form
- Injection, Solution
- Marketing category
- DRUG FOR FURTHER PROCESSING
- Marketed since
- May 1, 2017
- Listing expires
- December 31, 2026
Active ingredients
- Durvalumab 120 mg/2.4mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 61434-038-02 | 288 VIAL in 1 CASE (61434-038-02) / 2.4 mL in 1 VIAL |